Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection

References

• Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10:98–109.
   PubMed Web of Science ®Google Scholar
• Drueke TB. Cell biology of parathyroid gland hyperplasia in chronic renal failure. J Am Soc Nephrol. 2000;11:1141–1152.
   PubMed Web of Science ®Google Scholar
• Goldsmith D, Kothawala P, Chalian A, et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of fracture and need for parathyroidectomy in CKD. Am J Kidney Dis. 2009;53:1002–1013.
   PubMed Web of Science ®Google Scholar
• Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26:1948–1955.
   PubMed Web of Science ®Google Scholar
• Ossareh S. Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients. Int J Nephrol Renovasc Dis. 2014;7:161–168.
   PubMedGoogle Scholar
• Lloret MJ, Ruiz-Garcia C, Dasilva I, et al. Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence. Patient Prefer Adherence. 2013;7:1147–1156.
   PubMed Web of Science ®Google Scholar
• Pandey R, Zella J, Clagett-Dame M, et al. Use of 2MD, a novel oral calcitriol analog, in hemodialysis patients with secondary hyperparathyroidism. Am J Nephrol. 2016;43:213–220.
   PubMed Web of Science ®Google Scholar
• Rauscher S, Lafrance JP, Pichette V, et al. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients. Int Urol Nephrol. 2017;49:325–328.
   PubMed Web of Science ®Google Scholar
• Akizawa T, Akiba T, Hirakata H, et al. Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial. 2015;19:225–234.
   PubMed Web of Science ®Google Scholar
• Adachi M, Miyoshi T, Shiraishi N, et al. A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism. CN. 2011;76:266–272.
   Web of Science ®Google Scholar
• Akizawa T, Kurita N, Mizobuchi M, et al. PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism. Sci Rep. 2016;6:19612.
   PubMed Web of Science ®Google Scholar
• Kuczera P, Adamczak M, Wiecek A. Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism. BMC Nephrol. 2016;17:176.
   PubMed Web of Science ®Google Scholar
• Moe SM, Drüeke TB, Block GA, et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;S1–S130.
   Google Scholar
• Chen HH, Lin CJ, Wu CJ, et al. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg. 2011;253:786–790.
   PubMed Web of Science ®Google Scholar
• Yu MA, Yao L, Zhang L, et al. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperthermia. 2016;32:180–186.
   PubMed Web of Science ®Google Scholar
• Zhuo L, Peng LL, Zhang YM, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease-a pilot study. Radiology. 2017;282:576–584.
   PubMed Web of Science ®Google Scholar
• Machi J. Radiofrequency ablation for hyperparathyroidism: can it be a new treatment?. Surg Laparosc Endosc Percutan Tech. 2006;16:116–16773016.
   PubMed Web of Science ®Google Scholar
• Saad WE, Wallace MJ, Wojak JC, et al. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol. 2010;21:789–795.
   PubMed Web of Science ®Google Scholar
• Lewis CA, Allen TE, Burke DR, et al. Quality improvement guidelines for central venous access. The Standards of Practice Committee of the Society of Cardiovascular & Interventional Radiology. J Vasc Interv Radiol. 1997;8:475–479.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273:241–260.
   PubMed Web of Science ®Google Scholar
• Singh Ospina N, Thompson GB, Lee RA, et al. Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2009;113:S1–S130.
   PubMed Web of Science ®Google Scholar
• Alherabi AZ, Marglani OA, Alfiky MG, et al. Percutaneous ultrasound-guided alcohol ablation of solitary parathyroid adenoma in a patient with primary hyperparathyroidism. Am J Otolaryngol. 2015;36:701–703.
   PubMed Web of Science ®Google Scholar
• Onoda N, Kurihara S, Sakurai Y, et al. A case of secondary hyperparathyroidism whose high turnover bone improved after the direct injection of acetic acid into the parathyroid glands. CN. 2004;61:68–73.
   Google Scholar
• Junik R, Polańska M, Manitius J, et al. Local calcitriol injections as a suppressive treatment of secondary hyperparathyroidism in chronic dialysis patients. Ren Fail. 2007;29:941–945.
   PubMed Web of Science ®Google Scholar
• Sormaz IC, Poyanli A, Acar S, et al. The results of ultrasonography-guided percutaneous radiofrequency ablation in hyperparathyroid patients in whom surgery is not feasible. Cardiovasc Intervent Radiol. 2017;40:596–602.
   PubMed Web of Science ®Google Scholar
• Wang R, Jiang T, Chen Z, et al. Regression of calcinosis following treatment with radiofrequency thermoablation for severe secondary hyperparathyroidism in a hemodialysis patient. Intern Med. 2013;52:583–587.
   PubMed Web of Science ®Google Scholar
• Adda G, Scillitani A, Epaminonda P, et al. Ultrasound-guided laser thermal ablation for parathyroid adenomas: analysis of three cases with a three-year follow-up. Horm Res Paediatr. 2006;65:231–234.
   Web of Science ®Google Scholar
• Ambrosini CE, Cianferotti L, Picone A, et al. High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: a preliminary experience. J Endocrinol Invest. 2011;34:655–659.
   PubMed Web of Science ®Google Scholar
• Kovatcheva R, Vlahov J, Stoinov J, et al. US-guided high-intensity focused ultrasound as a promising non-invasive method for treatment of primary hyperparathyroidism. Eur Radiol. 2014;24:2052–2058.
   PubMed Web of Science ®Google Scholar
• Wang G, Liu S, Liu X, et al. Microwave ablation: an effective treatment for mild-to-moderate secondary hyperparathyroidism in patients undergoing haemodialysis. Int J Hyperthermia. 2017;33:946–952.
   PubMed Web of Science ®Google Scholar
• Diao Z, Wang L, Li D, et al. Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis. Ren Fail. 2017;39:140–145.
   PubMed Web of Science ®Google Scholar
• Fletcher S, Kanagasundaram NS, Rayner HC, et al. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant. 1998;13:3111–3117.
   PubMed Web of Science ®Google Scholar
• Stratigis S, Stylianou K, Mamalaki E, et al. Percutaneous ethanol injection therapy: a surgery-sparing treatment for primary hyperparathyroidism. Clin Endocrinol (Oxf). 2008;69:542–548.
   PubMed Web of Science ®Google Scholar
• Andreano A, Huang Y, Meloni MF, et al. Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue. Med Phys. 2010;37:2967–2973.
   PubMed Web of Science ®Google Scholar
• Lubner MG, Hinshaw JL, Andreano A, et al. High-powered microwave ablation with a small-gauge, gas-cooled antenna: initial ex vivo and in vivo results. J Vasc Interv Radiol. 2012;23:405–411.
   PubMed Web of Science ®Google Scholar
• Parikh PP, Farra JC, Allan BJ, et al. Long-term effectiveness of localization studies and intraoperative parathormone monitoring in patients undergoing reoperative parathyroidectomy for persistent or recurrent hyperparathyroidism. Am J Surg. 2015;210:117–122.
   PubMed Web of Science ®Google Scholar
• Norlen O, Wang KC, Tay YK, et al. No need to abandon focused parathyroidectomy: a multicenter study of long-term outcome after surgery for primary hyperparathyroidism. Ann Surg. 2015;261:991–996.
   PubMed Web of Science ®Google Scholar
• Schlosser K, Bartsch DK, Diener MK, et al. Total parathyroidectomy with routine thymectomy and autotransplantation versus total parathyroidectomy alone for secondary hyperparathyroidism: results of a nonconfirmatory multicenter prospective randomized controlled pilot trial. Ann Surg. 2016;264:745–753.
   PubMed Web of Science ®Google Scholar
• Stracke S, Keller F, Steinbach G, et al. Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism. Nephron Clin Pract. 2009;111:c102–c109.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang M, Du S, et al. Impact of parathyroidectomy on survival among haemodialysis patients: a prospective cohort study. Nephrology. 2016;21:133–138.
   PubMed Web of Science ®Google Scholar
• Chuang CH, Wang JJ, Weng SF, et al. Epidemiology and mortality among dialysis patients with parathyroidectomy: Taiwan National Cohort Study. JN. 2013;26:1143–1150.
   Web of Science ®Google Scholar
• Iwamoto N, Sato N, Nishida M, et al. Total parathyroidectomy improves survival of hemodialysis patients with secondary hyperparathyroidism. JN. 2012;25:755–763.
   Web of Science ®Google Scholar
• Kestenbaum B, Andress DL, Schwartz SM, et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int. 2004;66:2010–2016.
   PubMed Web of Science ®Google Scholar
• Rajeev P, Stechman MJ, Kirk H, et al. Safety and efficacy of minimally-invasive parathyroidectomy (MIP) under local anaesthesia without intra-operative PTH measurement. Int J Surg. 2013;11:275–277.
   PubMed Web of Science ®Google Scholar
• Tominaga Y, Kakuta T, Yasunaga C, et al. Evaluation of parathyroidectomy for secondary and tertiary hyperparathyroidism by the parathyroid surgeons' society of Japan. Ther Apher Dial. 2016;20:6–11.
   PubMed Web of Science ®Google Scholar
• Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg. 2011;253:585–591.
   PubMed Web of Science ®Google Scholar
• Richmond BK, Eads K, Flaherty S, et al. Complications of thyroidectomy and parathyroidectomy in the rural community hospital setting. Am Surg. 2007;73:332–336.
   PubMed Web of Science ®Google Scholar